Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Caitlin C Chrystoja

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Clinical Chemistry|November 15, 2013
Whole genome sequencing as a diagnostic test: challenges and opportunitiesCaitlin C Chrystoja, Eleftherios P Diamandis
BMC Medicine|April 21, 2012
Bioinformatic identification of proteins with tissue-specific expression for biomarker discoveryIoannis Prassas, Caitlin C Chrystoja, Shalini Makawita, et al.
Clinical Chemistry|November 9, 2012
Pancreatic cancerCaitlin C Chrystoja, Eleftherios P Diamandis, Randall Brand, et al.
Clinical Chemistry|October 8, 2013
False biomarker discovery due to reactivity of a commercial ELISA for CUZD1 with cancer antigen CA125Ioannis Prassas, Davor Brinc, Sofia Farkona, et al.
The American Journal of Gastroenterology|September 14, 2016
Achalasia-Specific Quality of Life After Pneumatic Dilation or Laparoscopic Heller Myotomy With Partial Fundoplication: A Multicenter, Randomized Clinical TrialCaitlin C Chrystoja, Gail E Darling, Nicholas E Diamant, et al.
Molecular & Cellular Proteomics : MCP|June 27, 2013
Laminin, gamma 2 (LAMC2): a promising new putative pancreatic cancer biomarker identified by proteomic analysis of pancreatic adenocarcinoma tissuesHari Kosanam, Ioannis Prassas, Caitlin C Chrystoja, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Clinical Chemistry|November 15, 2013
Whole genome sequencing as a diagnostic test: challenges and opportunitiesCaitlin C Chrystoja, Eleftherios P Diamandis
BMC Medicine|April 21, 2012
Bioinformatic identification of proteins with tissue-specific expression for biomarker discoveryIoannis Prassas, Caitlin C Chrystoja, Shalini Makawita, et al.
Clinical Chemistry|November 9, 2012
Pancreatic cancerCaitlin C Chrystoja, Eleftherios P Diamandis, Randall Brand, et al.
Clinical Chemistry|October 8, 2013
False biomarker discovery due to reactivity of a commercial ELISA for CUZD1 with cancer antigen CA125Ioannis Prassas, Davor Brinc, Sofia Farkona, et al.
The American Journal of Gastroenterology|September 14, 2016
Achalasia-Specific Quality of Life After Pneumatic Dilation or Laparoscopic Heller Myotomy With Partial Fundoplication: A Multicenter, Randomized Clinical TrialCaitlin C Chrystoja, Gail E Darling, Nicholas E Diamant, et al.
Molecular & Cellular Proteomics : MCP|June 27, 2013
Laminin, gamma 2 (LAMC2): a promising new putative pancreatic cancer biomarker identified by proteomic analysis of pancreatic adenocarcinoma tissuesHari Kosanam, Ioannis Prassas, Caitlin C Chrystoja, et al.
Pageof 1